AlphaYouOA
Schedule 13D filing
ORBIMED ADVISORS LLC disclosed a 14% stake in ADARx Pharmaceuticals, Inc. (ADRX)
ORBIMED ADVISORS LLC reported owning 14% of ADARx Pharmaceuticals, Inc. (ADRX) (14,913,764 shares) in a Schedule 13D filed Oct 2, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 2, 2026
- Source
- Schedule 13D
More ADRX insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.